Role of the treating surgeon in the consent process for elective refractive surgery

Steven C Schallhorn,1–3 Stephen J Hannan,3 David Teenan,3 Julie M Schallhorn1 1Department of Ophthalmology, University of California, San Francisco, San Francisco, 2Roski Eye Institute, University of Southern California, Los Angeles, CA, USA; 3Optical Express, Glasgow, UK Purpose: To com...

Full description

Bibliographic Details
Main Authors: Schallhorn SC, Hannan SJ, Teenan D, Schallhorn JM
Format: Article
Language:English
Published: Dove Medical Press 2016-11-01
Series:Clinical Ophthalmology
Subjects:
Online Access:https://www.dovepress.com/role-of-the-treating-surgeon-in-the-consent-process-for-elective-refra-peer-reviewed-article-OPTH
id doaj-1e9fbb97b3764044b20248f0394cd8bc
record_format Article
spelling doaj-1e9fbb97b3764044b20248f0394cd8bc2020-11-24T23:39:13ZengDove Medical PressClinical Ophthalmology1177-54832016-11-01Volume 102391240230247Role of the treating surgeon in the consent process for elective refractive surgerySchallhorn SCHannan SJTeenan DSchallhorn JMSteven C Schallhorn,1–3 Stephen J Hannan,3 David Teenan,3 Julie M Schallhorn1 1Department of Ophthalmology, University of California, San Francisco, San Francisco, 2Roski Eye Institute, University of Southern California, Los Angeles, CA, USA; 3Optical Express, Glasgow, UK Purpose: To compare patient’s perception of consent quality, clinical and quality-of-life outcomes after laser vision correction (LVC) and refractive lens exchange (RLE) between patients who met their treating surgeon prior to the day of surgery (PDOS) or on the day of surgery (DOS). Design: Retrospective, comparative case series. Setting: Optical Express, Glasgow, UK. Methods: Patients treated between October 2015 and June 2016 (3972 LVC and 979 RLE patients) who attended 1-day and 1-month postoperative aftercare and answered a questionnaire were included in this study. All patients had a thorough preoperative discussion with an optometrist, watched a video consent, and were provided with written information. Patients then had a verbal discussion with their treating surgeon either PDOS or on the DOS, according to patient preference. Preoperative and 1-month postoperative visual acuity, refraction, preoperative, 1-day and 1-month postoperative questionnaire were compared between DOS and PDOS patients. Multivariate regression model was developed to find factors associated with patient’s perception of consent quality. Results: Preoperatively, 8.0% of LVC and 17.1% of RLE patients elected to meet their surgeon ahead of the surgery day. In the LVC group, 97.5% of DOS and 97.2% of PDOS patients indicated they were properly consented for surgery (P=0.77). In the RLE group, 97.0% of DOS and 97.0% of PDOS patients stated their consent process for surgery was adequate (P=0.98). There was no statistically significant difference between DOS and PDOS patients in most of the postoperative clinical or questionnaire outcomes. Factors predictive of patient’s satisfaction with consent quality were postoperative satisfaction with vision (46.7% of explained variance), difficulties with night driving, close-up vision or outdoor/sports activities (25.4%), visual phenomena (12.2%), dry eyes (7.5%), and patient’s satisfaction with surgeon’s care (8.2%). Conclusion: Perception of quality of consent was comparable between patients that elected to meet the surgeon PDOS, and those who did not. Keywords: consent process, refractive surgery, laser vision correction, refractive lens exchange, quality of life outcomeshttps://www.dovepress.com/role-of-the-treating-surgeon-in-the-consent-process-for-elective-refra-peer-reviewed-article-OPTHConsent processrefractive surgerylaser vision correctionrefractive lens exchangequality of life outcomes
collection DOAJ
language English
format Article
sources DOAJ
author Schallhorn SC
Hannan SJ
Teenan D
Schallhorn JM
spellingShingle Schallhorn SC
Hannan SJ
Teenan D
Schallhorn JM
Role of the treating surgeon in the consent process for elective refractive surgery
Clinical Ophthalmology
Consent process
refractive surgery
laser vision correction
refractive lens exchange
quality of life outcomes
author_facet Schallhorn SC
Hannan SJ
Teenan D
Schallhorn JM
author_sort Schallhorn SC
title Role of the treating surgeon in the consent process for elective refractive surgery
title_short Role of the treating surgeon in the consent process for elective refractive surgery
title_full Role of the treating surgeon in the consent process for elective refractive surgery
title_fullStr Role of the treating surgeon in the consent process for elective refractive surgery
title_full_unstemmed Role of the treating surgeon in the consent process for elective refractive surgery
title_sort role of the treating surgeon in the consent process for elective refractive surgery
publisher Dove Medical Press
series Clinical Ophthalmology
issn 1177-5483
publishDate 2016-11-01
description Steven C Schallhorn,1–3 Stephen J Hannan,3 David Teenan,3 Julie M Schallhorn1 1Department of Ophthalmology, University of California, San Francisco, San Francisco, 2Roski Eye Institute, University of Southern California, Los Angeles, CA, USA; 3Optical Express, Glasgow, UK Purpose: To compare patient’s perception of consent quality, clinical and quality-of-life outcomes after laser vision correction (LVC) and refractive lens exchange (RLE) between patients who met their treating surgeon prior to the day of surgery (PDOS) or on the day of surgery (DOS). Design: Retrospective, comparative case series. Setting: Optical Express, Glasgow, UK. Methods: Patients treated between October 2015 and June 2016 (3972 LVC and 979 RLE patients) who attended 1-day and 1-month postoperative aftercare and answered a questionnaire were included in this study. All patients had a thorough preoperative discussion with an optometrist, watched a video consent, and were provided with written information. Patients then had a verbal discussion with their treating surgeon either PDOS or on the DOS, according to patient preference. Preoperative and 1-month postoperative visual acuity, refraction, preoperative, 1-day and 1-month postoperative questionnaire were compared between DOS and PDOS patients. Multivariate regression model was developed to find factors associated with patient’s perception of consent quality. Results: Preoperatively, 8.0% of LVC and 17.1% of RLE patients elected to meet their surgeon ahead of the surgery day. In the LVC group, 97.5% of DOS and 97.2% of PDOS patients indicated they were properly consented for surgery (P=0.77). In the RLE group, 97.0% of DOS and 97.0% of PDOS patients stated their consent process for surgery was adequate (P=0.98). There was no statistically significant difference between DOS and PDOS patients in most of the postoperative clinical or questionnaire outcomes. Factors predictive of patient’s satisfaction with consent quality were postoperative satisfaction with vision (46.7% of explained variance), difficulties with night driving, close-up vision or outdoor/sports activities (25.4%), visual phenomena (12.2%), dry eyes (7.5%), and patient’s satisfaction with surgeon’s care (8.2%). Conclusion: Perception of quality of consent was comparable between patients that elected to meet the surgeon PDOS, and those who did not. Keywords: consent process, refractive surgery, laser vision correction, refractive lens exchange, quality of life outcomes
topic Consent process
refractive surgery
laser vision correction
refractive lens exchange
quality of life outcomes
url https://www.dovepress.com/role-of-the-treating-surgeon-in-the-consent-process-for-elective-refra-peer-reviewed-article-OPTH
work_keys_str_mv AT schallhornsc roleofthetreatingsurgeonintheconsentprocessforelectiverefractivesurgery
AT hannansj roleofthetreatingsurgeonintheconsentprocessforelectiverefractivesurgery
AT teenand roleofthetreatingsurgeonintheconsentprocessforelectiverefractivesurgery
AT schallhornjm roleofthetreatingsurgeonintheconsentprocessforelectiverefractivesurgery
_version_ 1725514615389945856